Event calendar

December 5, 2023 Arctic Life Science Investor Day

November 23, 2023 Redeye Life Science Day 2023

November 23, 2023 SEB Healthcare Seminar

November 22, 2023 ABGSC Life Science Days 2023

October 26, 2023 BioStock Life Science Summit 2023

October 25, 2023 Q3 interim report and presentation

October 11, 2023 Redeye Neurology Seminar

September 14, 2023 Pareto Healthcare Conference

August 30, 2023 ABGSC Investor Day

August 27, 2023 MDS Congress 2023

August 22, 2023 Webcast for investors, analysts, and media concerning mesdopetam project

June 13, 2023 IBAGS 2023

June 1, 2023 Redeye Growth Day 2023

May 30, 2023 ABGSC Life Science Summit 2023

May 10, 2023 Q1 interim report and presentation

March 31, 2023 Industry symposium at AD/PD 2023, Gothenburg

March 28, 2023 AD/PD 2023, Gothenburg

March 8, 2023 ABGSC Investor Days

February 23, 2023 Year-end report and presentation

February 9, 2023 Sahlgrenska Academy Junior Research Symposium

January 8, 2023 6th Annual Neuroscience Innovation Forum

December 15, 2022 DNB Nordic Healthcare Conference 2022

November 24, 2022 Redeye Life Science Summit

November 21, 2022 SEB Healthcare Seminar

November 15, 2022 Neuroscience 2022 by Society for Neuroscience

November 14, 2022 LSX Inv€$tival Showcase in London

November 9, 2022 Q3 interim report + broadcast

October 12, 2022 Redeye Neurology Seminar

September 29, 2022 ProHearings shared CMD

September 13, 2022 ABGSC Investor Day

September 8, 2022 Pareto Securities’ 13th Annual Healthcare Conference

June 2, 2022 Redeye Growth Day 2022

May 19, 2022 ABGSC Life Science Summit

May 16, 2022 Aktiedagen Gothenburg, Aktiespararna

May 11, 2022 Annual General Meeting 2022

May 11, 2022 Q1 interim report + earnings call

March 22, 2022 Capital Markets Day

February 23, 2022 Year-end Report, 2021

November 16, 2021 Jefferies London Healthcare Conference 2021

November 11, 2021 Redeye Life Science Day 2021

November 10, 2021 Interim Report Q3, 2021

October 25, 2021 BIO-Europe Digital 2021

October 13, 2021 Redeye CNS Seminar

September 14, 2021 ABGSC Investor Day Seminar

September 6, 2021 LSX Nordic Congress Virtual 2021

September 2, 2021 Pareto Securities’ 12th Annual Healthcare Conference 2021

August 26, 2021 Prohearings shared CMD in August

August 25, 2021 Interim Report Q2, 2021

June 2, 2021 Redeye Growth Day 2021

May 25, 2021 ABGSC Life Science Summit 2021

May 6, 2021 Annual General Meeting, Gothenburg

May 6, 2021 Interim Report Q1, 2021

April 23, 2021 Prohearings shared CMD in April – cancelled

March 22, 2021 BIO-Europe Spring Digital 2021

March 12, 2021 Carnegie Nordic Virtual Healthcare Seminar 2021

February 24, 2021 Year-end Report, 2020

January 18, 2021 SEB Healthcare seminar 2021

December 3, 2020 Redeye investor forum, Gothenburg

November 26, 2020 Redeye Life Science Day 2020

November 17, 2020 Jefferies Virtual London Healthcare Conference 2020, Nov 17-19

November 11, 2020 Interim report Q3, 2020

October 26, 2020 BIO-Europe 2020 – Digital

October 16, 2020 ProHearings capital market day

October 15, 2020 Redeye’s Neurology seminar

September 3, 2020 Pareto Securities’ 11th annual Healthcare Conference, Stockholm

August 26, 2020 Interim report Q2, 2020

June 8, 2020 BIO Digital 2020

June 2, 2020 Redeye Growth Day 2020, Digital

May 26, 2020 ABG Sundal Collier Life science summit, Stockholm

May 18, 2020 Aktiedagen

May 7, 2020 Annual General Meeting 2020

May 7, 2020 Interim report Q1, 2020

April 7, 2020 Annual report 2019

March 4, 2020 Life Sciencedagen, Gothenburg

March 3, 2020 Carnegie Annual Nordic Healthcare Seminar, Stockholm

February 19, 2020 Börsveckans Småbolagsdag 2020, Stockholm

February 6, 2020 Year-end report (Q4), 2019

February 4, 2020 Investor AW event, Gothenburg

November 7, 2019 Interim report Q3, 2019

September 22, 2019 International Congress of Parkinson’s Disease and Movement Disorders, Nice

August 28, 2019 Interim report Q2, 2019

April 25, 2019 Interim report Q1, 2019

April 25, 2019 Annual general meeting 2019

April 3, 2019 Annual report 2018

February 27, 2019 Full year report, 2018

November 14, 2018 Interim report Q3, 2018